Isolation of mesenchymal stem cells from Pap smear samples

Area of Science:

• Stem cell biology
• Regenerative medicine
• Gynecologic pathology

Background:

• Mesenchymal stem cells (MSCs) possess multipotent differentiation and paracrine capabilities, making them valuable for treating tissue injuries and autoimmune diseases.
• Papanicolaou (Pap) tests, routine cervical screenings, yield samples containing cervical cells, offering a potential source for stem cell isolation.
• Identifying novel, accessible sources of MSCs is crucial for advancing stem cell therapy and regenerative medicine.

Purpose of the Study:

• To identify and isolate stem cells from Pap smear samples of pregnant women.
• To determine the origin of these stem cells (maternal or fetal).
• To characterize the stem cell properties of the isolated cells.

Main Methods:

• Established 6 mesenchymal stem cell (MSC) lines from Pap smear samples of 60 pregnant women.
• Selected 3 cell lines for further characterization.
• Assessed proliferation rates, MSC characteristics, and differentiation capacity (adipocytes, osteocytes, chondrocytes).

Main Results:

• Successfully established uterine cervical stromal cells (UCSCs) from Pap smear samples with a 10% efficiency.
• The isolated UCSCs exhibited high proliferation rates and typical MSC characteristics.
• Demonstrated the differentiation potential of UCSCs into adipocytes, osteocytes, and chondrocytes.

Conclusions:

• Pap smear samples can serve as a source for isolating human uterine cervical stromal cells (UCSCs).
• Despite low establishment efficiency, UCSCs represent a simple, safe, low-cost, and donor-specific source for MSCs.
• UCSCs hold promise for applications in stem cell therapy and regenerative medicine.